Prelude Therapeutics Incorporated (NASDAQ:PRLD), a clinical-stage biopharmaceutical company focused on developing novel precision medicines for cancer treatment, stands at a critical juncture in its ...
Prelude Therapeutics Inc (NASDAQ:PRLD), a small-cap biotechnology company with a market capitalization of $41 million, is navigating a critical phase in its development as it advances multiple assets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results